Merck Serono Vigorskin K1 Plus Crema Per Lesioni Cutanee Non Infette 100 Ml
PDF] Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer. | Semantic Scholar